Genomic Testing for Improved Cancer Diagnosis and Treatment in Nigeria

Strategic Insights -

The Society for Cellular Pathology Scientists of Nigeria (SCPSN) has emphasized the importance of adopting genomic testing for improved cancer diagnosis, treatment, and prevention. At the eighth International Scientific Conference/Annual General Meeting of the association in Lagos, the National President, Dr Jonathan Madukwe, called for the adoption of genomic testing, citing its ability to provide genetic, molecular, and heterogeneous information on cancer causes. Lifestyle changes, environmental, and dietary factors were identified as major contributing elements of cancer disease.

Key Takeaways:

  • The SCPSN advocates for the adoption of genomic testing for improved cancer diagnosis, treatment, and prevention in Nigeria.
  • Dr Jonathan Madukwe identified lifestyle changes, environmental, and dietary factors as major contributors to cancer disease, emphasizing the need to avoid these risk factors.
  • Genomic testing provides more accurate, reliable, and effective results for palliative care of cancer disease, as stated by Professor Francisca Nwokorie.
  • The University of Lagos and Lagos University Teaching Hospital have acquired new-generation genomic testing equipment, but the Federal Government is urged to provide an enabling environment for the provision and accessibility of these equipment.
  • The Local Organising Committee Chairman, Mr Daniel Osiagwu, encouraged the public to embrace genomic testing for effective treatment, while deploring the high cost of the equipment and urging the government to subsidize it.
  • The conference aimed to promote collaboration, innovation, and excellence in histopathology practice for improved healthcare outcomes and service delivery.

Statistics:

  • 10 years: The time frame in which environment and lifestyle changes have rapidly contributed to changes in cancer cells and resulting increases in cancer cases.
  • 8th International Scientific Conference/Annual General Meeting: The conference where the SCPSN called for the adoption of genomic testing.
  • 2: The number of institutions in Lagos (University of Lagos and Lagos University Teaching Hospital) that have acquired new-generation genomic testing equipment.
  • Pandemic: The global health crisis that has highlighted the need for effective cancer diagnosis and treatment.

Sources:

  • News Agency of Nigeria
  • Society for Cellular Pathology Scientists of Nigeria (SCPSN)
  • University of Lagos
  • Lagos University Teaching Hospital
  • Federal Government of Nigeria